603233 大参林
已收盘 05-19 15:00:00
资讯
新帖
简况
大参林(603233)披露2025年年度股东会决议公告,5月18日股价下跌5.42%
证券之星 · 05-18 22:15
大参林(603233)披露2025年年度股东会决议公告,5月18日股价下跌5.42%
大参林跌5.42% 华创证券上周四刚维持推荐评级
中金财经 · 05-18 17:17
大参林跌5.42% 华创证券上周四刚维持推荐评级
5月18日大参林跌5.42%,兴全有机增长混合基金重仓该股
中金财经 · 05-18 16:34
5月18日大参林跌5.42%,兴全有机增长混合基金重仓该股
每周股票复盘:大参林(603233)2025年净利增35.04%
证券之星 · 05-10
每周股票复盘:大参林(603233)2025年净利增35.04%
大参林(603233)披露2025年度股东会会议材料,5月8日股价上涨0.32%
证券之星 · 05-08
大参林(603233)披露2025年度股东会会议材料,5月8日股价上涨0.32%
中邮证券:给予大参林买入评级
证券之星 · 04-28
中邮证券:给予大参林买入评级
股市必读:大参林年报 - 第四季度单季净利润同比增长172.37%
证券之星 · 04-27
股市必读:大参林年报 - 第四季度单季净利润同比增长172.37%
每周股票复盘:大参林(603233)一季度净利增11.12%
证券之星 · 04-26
每周股票复盘:大参林(603233)一季度净利增11.12%
大参林(603233)披露董事、高级管理人员薪酬管理制度,4月24日股价上涨1.17%
证券之星 · 04-24
大参林(603233)披露董事、高级管理人员薪酬管理制度,4月24日股价上涨1.17%
国金证券:给予大参林买入评级
证券之星 · 04-24
国金证券:给予大参林买入评级
大参林最新公告:第一季度净利润同比增长11.12%
证券之星 · 04-23
大参林最新公告:第一季度净利润同比增长11.12%
每周股票复盘:大参林(603233)完成董事会换届选举
证券之星 · 04-05
每周股票复盘:大参林(603233)完成董事会换届选举
大参林(603233)披露可转债转股结果暨股份变动公告,4月3日股价下跌0.67%
证券之星 · 04-03
大参林(603233)披露可转债转股结果暨股份变动公告,4月3日股价下跌0.67%
3月23日大参林跌6.24%,安信医药健康股票A基金重仓该股
证券之星 · 03-23
3月23日大参林跌6.24%,安信医药健康股票A基金重仓该股
每周股票复盘:大参林(603233)拟增设联席总经理职位
证券之星 · 03-22
每周股票复盘:大参林(603233)拟增设联席总经理职位
每周股票复盘:大参林(603233)拟向天宸健康增资2亿元
证券之星 · 03-15
每周股票复盘:大参林(603233)拟向天宸健康增资2亿元
大参林(603233)披露召开2026年第一次临时股东大会通知,3月13日股价下跌0.68%
证券之星 · 03-13
大参林(603233)披露召开2026年第一次临时股东大会通知,3月13日股价下跌0.68%
女子称用药后耳聋药店不管治疗费 大参林称需医院证明
中金财经 · 02-27
女子称用药后耳聋药店不管治疗费 大参林称需医院证明
每周股票复盘:大参林(603233)为12家子公司担保9.85亿元
证券之星 · 01-25
每周股票复盘:大参林(603233)为12家子公司担保9.85亿元
大参林:公司不存在逾期担保
证券日报 · 01-22
大参林:公司不存在逾期担保
加载更多
公司概况
公司名称:
大参林医药集团股份有限公司
所属行业:
零售业
上市日期:
2017-07-31
主营业务:
大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。公司荣获的社会地位及行业荣誉:“大参林”已成为“中国驰名商标”和“广东省著名商标”。公司业务范围覆盖广东、广西、河南、黑龙江、江苏、新疆、辽宁、四川、重庆、河北、陕西、江西、山西、浙江、湖北、山东、福建、安徽、海南、上海、内蒙古等21个省(含自治区、直辖市),其中,广东、广西、河南和黑龙江的竞争优势明显,省内市场份额名列前茅。在中国药店年度发展报告会上,公司荣获“2025-2026中国药店价值榜100强”第一名;荣获由广东医药商业协会颁发的“2024年度中国药品零售企业销售总额10强”;荣获中国药店颁发的“中国药店25周年影响力人物/品牌”;荣获广东工商业联合会颁发的“广东省百强民营企业”第55位及“广东省服务业民营企业50强”第18位;荣获由同花顺与财闻传联合主办的“2025财闻奖”颁发的“高质量上市公司奖”。
发行价格:
24.72
{"stockData":{"symbol":"603233","market":"SH","secType":"STK","nameCN":"大参林","latestPrice":17.79,"timestamp":1779174000000,"preClose":17.79,"halted":0,"volume":6756700,"delay":0,"changeRate":0,"floatShares":1139000000,"shares":1139000000,"eps":1.1296,"marketStatus":"已收盘","change":0,"latestTime":"05-19 15:00:00","open":17.66,"high":17.91,"low":17.5,"amount":120000000,"amplitude":0.023,"askPrice":17.8,"askSize":38,"bidPrice":17.79,"bidSize":42,"shortable":0,"etf":0,"ttmEps":1.1296,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"adjPreClose":17.79,"symbolType":"stock","openAndCloseTimeList":[[1779154200000,1779161400000],[1779166800000,1779174000000]],"highLimit":19.57,"lowLimit":16.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1138848067,"isCdr":false,"pbRate":2.64,"roa":"--","peRate":15.748938,"roe":"6.3%","epsLYR":1.08,"committee":-0.155,"marketValue":20260000000,"turnoverRate":0.0059,"status":2,"floatMarketCap":20260000000},"requestUrl":"/m/hq/s/603233","defaultTab":"news","newsList":[{"id":"2636071085","title":"大参林(603233)披露2025年年度股东会决议公告,5月18日股价下跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636071085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636071085?lang=zh_cn&edition=full","pubTime":"2026-05-18 22:15","pubTimestamp":1779113718,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘,大参林报收于17.79元,较前一交易日下跌5.42%,最新总市值为202.6亿元。该股当日开盘18.81元,最高18.82元,最低17.14元,成交额达3.65亿元,换手率为1.82%。近日,大参林医药集团股份有限公司披露《2025年年度股东会决议公告》。公告显示,公司于2026年5月18日召开2025年年度股东会,会议由董事会召集,董事谭群飞主持,采用现场与网络投票方式举行,出席股东所持表决权股份占公司有表决权总股份的75.1865%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800037321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0209","603233","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636002980","title":"大参林跌5.42% 华创证券上周四刚维持推荐评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2636002980","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636002980?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:17","pubTimestamp":1779095823,"startTime":"0","endTime":"0","summary":"中国经济网北京5月18日讯 大参林(603233.SH)股价今日下跌,截至收盘报17.79元,跌幅5.42%。\r\n\r\n 华创证券有限责任公司研究员郑辰、高初蕾5月14日发布研报《大参林(603233)2025年报及2026年一季报点评:盈利能力持续改善 大举分红回报股东》称,维持“推荐”评级。\r\n\r\n (责任编辑:徐自立)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260518/32233120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161027","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636102564","title":"5月18日大参林跌5.42%,兴全有机增长混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636102564","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636102564?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:34","pubTimestamp":1779093254,"startTime":"0","endTime":"0","summary":"证券之星消息,5月18日大参林跌5.42%,收盘报17.79元,换手率1.82%,成交量20.7万手,成交额3.65亿元。重仓大参林的公募基金请见下表:该股最近90天内共有9家机构给出评级,买入评级8家,增持评级1家;过去90天内机构目标均价为25.21。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为兴证全球基金的兴全有机增长混合。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/18/20260518757215.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/18/20260518757215.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260518/32232982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0185","BK0209","BK0114","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634641218","title":"每周股票复盘:大参林(603233)2025年净利增35.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634641218","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634641218?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:33","pubTimestamp":1778355190,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,大参林报收于18.55元,较上周的18.72元下跌0.91%。2025年实现营业收入275.02亿元,同比增长3.8%;归母净利润12.35亿元,同比增长35.04%。大参林医药集团股份有限公司将于2026年5月18日16:00-17:00通过上证路演中心网络互动方式召开2025年度暨2026年第一季度业绩说明会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603233","BK0114","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633443284","title":"大参林(603233)披露2025年度股东会会议材料,5月8日股价上涨0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633443284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633443284?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:12","pubTimestamp":1778235135,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,大参林报收于18.55元,较前一交易日上涨0.32%,最新总市值为211.26亿元。该股当日开盘18.48元,最高18.89元,最低18.32元,成交额达1.2亿元,换手率为0.57%。近日,大参林医药集团股份有限公司披露2025年度股东会会议材料。2025年实现营业收入275.02亿元,同比增长3.8%;归母净利润12.35亿元,同比增长35.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800033464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","603233","BK0114","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630589762","title":"中邮证券:给予大参林买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2630589762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630589762?lang=zh_cn&edition=full","pubTime":"2026-04-28 23:45","pubTimestamp":1777391121,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,龙永茂近期对大参林进行研究并发布了研究报告《利润增长超预期,多举措提升业绩释放潜力》,给予大参林买入评级。 盈利预测及投资建议 公司顺应行业周期,提质增效,利润释放潜力大,我们预计公司2026~2028营收分别为303.60、336.04、371.96亿元,归母净利润分别为14.86、16.57、18.76亿元,当前股价对应PE分别为14、13、11倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有3家机构给出评级,买入评级3家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800068209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630322093","title":"股市必读:大参林年报 - 第四季度单季净利润同比增长172.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630322093","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630322093?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:05","pubTimestamp":1777248322,"startTime":"0","endTime":"0","summary":"来自:2025年第四季度归母净利润同比上升172.37%,扣非净利润同比增幅达363.93%。股本股东变化股东户数变动近日大参林披露,截至2026年3月31日公司股东户数为2.54万户,较12月31日减少2706.0户,减幅为9.62%。大参林医药集团股份有限公司2025年度审计报告大参林医药集团股份有限公司2025年度财务报告由天健会计师事务所审计,审计意见为标准无保留意见。2025年度营业收入为2,750,218.84万元,同比增长3.80%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630060802","title":"每周股票复盘:大参林(603233)一季度净利增11.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630060802","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630060802?lang=zh_cn&edition=full","pubTime":"2026-04-26 05:40","pubTimestamp":1777153223,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,大参林报收于18.19元,较上周的17.39元上涨4.6%。本周关注点来自业绩披露要点:大参林2026年一季报显示,归母净利润5.11亿元,同比上升11.12%。股本股东变化截至2026年3月31日,大参林股东户数为2.54万户,较2025年12月31日减少2706户,减幅9.62%。天健会计师事务所审计认为,大参林于2025年12月31日在所有重大方面保持了有效的财务报告内部控制。大参林2025年度财务报告经天健会计师事务所审计,出具标准无保留意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","603233","BK0185","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629267817","title":"大参林(603233)披露董事、高级管理人员薪酬管理制度,4月24日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629267817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629267817?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:18","pubTimestamp":1777025899,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,大参林报收于18.19元,较前一交易日上涨1.17%,最新总市值为207.16亿元。近日,大参林医药集团股份有限公司披露《董事、高级管理人员薪酬管理制度》。薪酬与考核委员会负责制定薪酬政策并向董事会提出建议,董事薪酬由股东会决定,高级管理人员薪酬由董事会批准。公司将在财务报告错报或相关人员违规时追回已发薪酬。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400055003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0209","603233","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629789998","title":"国金证券:给予大参林买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629789998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629789998?lang=zh_cn&edition=full","pubTime":"2026-04-24 11:57","pubTimestamp":1777003077,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对大参林进行研究并发布了研究报告《零售毛利率提升,业绩持续向好》,给予大参林买入评级。 大参林 业绩简评 2026年4月23日,公司发布2025年年报。 风险提示 外延并购不确定性风险;处方外流不达预期风险;互联网冲击风险;收入地区集中风险等最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400036790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629871498","title":"大参林最新公告:第一季度净利润同比增长11.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629871498","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629871498?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:10","pubTimestamp":1776939012,"startTime":"0","endTime":"0","summary":"大参林(603233.SH)公告称,2026年第一季度实现营业收入69.73亿元,同比增长0.25%;归属于上市公司股东的净利润为5.11亿元,同比增长11.12%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300050325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625190856","title":"每周股票复盘:大参林(603233)完成董事会换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2625190856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625190856?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:38","pubTimestamp":1775331492,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,大参林报收于17.83元,较上周的17.56元上涨1.54%。公司公告汇总大参林医药集团股份有限公司于2026年3月31日召开第五届董事会第一次会议,以通讯方式举行,全体董事出席,会议选举柯云峰为董事长。大参林于2026年3月30日召开2026年第一次临时股东会,选举产生第五届董事会成员,包括非独立董事柯云峰、柯拓基、谭群飞、柯舟,职工代表董事柯国强,以及独立董事刘国常、杨小强、龚凯颂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","603233","BK0114","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624654818","title":"大参林(603233)披露可转债转股结果暨股份变动公告,4月3日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624654818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624654818?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:38","pubTimestamp":1775212695,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,大参林报收于17.83元,较前一交易日下跌0.67%,最新总市值为203.06亿元。公司于2026年4月3日披露《可转债转股结果暨股份变动公告》。公告显示,截至2026年3月31日,累计有365,000元“大参转债”转换为公司股份,占可转债发行总量的0.0260%,累计转股数量6,414股,占可转债转股前公司已发行股份总额的0.001%。2026年第一季度无新增转股。尚未转股的可转债金额为1,404,635,000元,占发行总量的99.9740%。股本结构未因转股发生变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0185","BK0209","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621775761","title":"3月23日大参林跌6.24%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621775761","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621775761?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:27","pubTimestamp":1774254446,"startTime":"0","endTime":"0","summary":"证券之星消息,3月23日大参林跌6.24%创60日新低,收盘报16.98元,换手率0.68%,成交量7.79万手,成交额1.34亿元。重仓大参林的前十大公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为3.62亿元,最新净值1.333,较上一交易日下跌1.69%,近一年上涨35.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300024992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0114","BK0209","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621799985","title":"每周股票复盘:大参林(603233)拟增设联席总经理职位","url":"https://stock-news.laohu8.com/highlight/detail?id=2621799985","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621799985?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:58","pubTimestamp":1774119490,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,大参林报收于18.11元,较上周的19.07元下跌5.03%。本周,大参林3月16日盘中最高价报19.13元。3月20日盘中最低价报18.05元。大参林当前最新总市值206.25亿元,在医药商业板块市值排名5/32,在两市A股市值排名985/5190。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0209","BK0114","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619370178","title":"每周股票复盘:大参林(603233)拟向天宸健康增资2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619370178","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619370178?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:46","pubTimestamp":1773513971,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,大参林报收于19.07元,较上周的19.82元下跌3.78%。本周关注点公司公告汇总:大参林拟向控股子公司天宸健康增资不超过20,000万元,拓展商业保险及DTP专业药房业务。公司全资子公司广东大参林贸易与关联方云眼智尚将按持股比例共同对天宸健康进行现金增资,总额不超过20,000万元,其中广东大参林贸易认缴不超过10,200万元,云眼智尚认缴不超过9,800万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0185","603233","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619115974","title":"大参林(603233)披露召开2026年第一次临时股东大会通知,3月13日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619115974","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619115974?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:42","pubTimestamp":1773412937,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,大参林报收于19.07元,较前一交易日下跌0.68%,最新总市值为217.18亿元。近日,大参林医药集团股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示,公司定于2026年3月30日召开2026年第一次临时股东会,会议采取现场投票与网络投票相结合方式,股权登记日为2026年3月24日。其中,修订《公司章程》为特别决议议案,需对中小投资者单独计票;第二项议案涉及关联股东回避表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300041899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0209","603233","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614288529","title":"女子称用药后耳聋药店不管治疗费 大参林称需医院证明","url":"https://stock-news.laohu8.com/highlight/detail?id=2614288529","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614288529?lang=zh_cn&edition=full","pubTime":"2026-02-27 13:57","pubTimestamp":1772171821,"startTime":"0","endTime":"0","summary":"中国经济网北京2月27日讯 紫牛新闻春节期间报道《女子称用了药店推荐药突然耳聋》显示,张女士前段时间左耳不舒服,到大参林大药房拿药时,店员称她是中耳炎,推荐了氧氟沙星滴耳液、过氧化氢消毒液,张女士滴到耳朵里后竟然聋了!经过治疗后,张女士听力有所好转,但4000多元治疗费药店却不管不问。药店负责人表示张女士的诉求需要医院提供确由药物导致耳聋的证明,如果没有,最多赔付200元,并让员工进行赔礼道歉。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260227/32031943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603233","BK0185","BK0114","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606234698","title":"每周股票复盘:大参林(603233)为12家子公司担保9.85亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234698?lang=zh_cn&edition=full","pubTime":"2026-01-25 01:36","pubTimestamp":1769276172,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,大参林报收于21.27元,较上周的19.0元上涨11.95%。本周,大参林1月23日盘中最高价报21.78元,股价触及近一年最高点。本周关注点公司公告汇总:大参林为12家子公司提供合计9.85亿元连带责任担保公司公告汇总大参林医药集团股份有限公司为满足子公司经营发展需要,近期为12家控股子公司向银行申请综合授信提供连带责任担保,担保金额合计98,500万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0209","603233","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605497855","title":"大参林:公司不存在逾期担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2605497855","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605497855?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:04","pubTimestamp":1769090640,"startTime":"0","endTime":"0","summary":"证券日报网讯 1月22日,大参林(维权)发布公告称,截至本公告披露日,公司及其子公司对外担保余额为人民币352250万元,占公司最近一期经审计的归属于上市公司股东净资产的比例为43.28%。上述对外担保总额全部为公司对控股子公司提供的担保,公司不存在对控股股东和实际控制人及其关联人提供担保情况,也不存在逾期对外担保情况。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-22/doc-inhieyhu1570580.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-22/doc-inhieyhu1570580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0114","603233","BK0209","BK0185"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779177045634,"stockEarnings":[{"period":"1week","weight":-0.0537},{"period":"1month","weight":0.023},{"period":"3month","weight":-0.0744},{"period":"6month","weight":-0.0166},{"period":"1year","weight":0.0394},{"period":"ytd","weight":0.0096}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0198},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0468},{"period":"1year","weight":0.2269},{"period":"ytd","weight":0.041}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"大参林医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"25410人(较上一季度减少9.62%)","perCapita":"44818股","listingDate":"2017-07-31","address":"广东省广州市荔湾区龙溪大道410号、410-1号","registeredCapital":"113884万元","survey":" 大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。公司荣获的社会地位及行业荣誉:“大参林”已成为“中国驰名商标”和“广东省著名商标”。公司业务范围覆盖广东、广西、河南、黑龙江、江苏、新疆、辽宁、四川、重庆、河北、陕西、江西、山西、浙江、湖北、山东、福建、安徽、海南、上海、内蒙古等21个省(含自治区、直辖市),其中,广东、广西、河南和黑龙江的竞争优势明显,省内市场份额名列前茅。在中国药店年度发展报告会上,公司荣获“2025-2026中国药店价值榜100强”第一名;荣获由广东医药商业协会颁发的“2024年度中国药品零售企业销售总额10强”;荣获中国药店颁发的“中国药店25周年影响力人物/品牌”;荣获广东工商业联合会颁发的“广东省百强民营企业”第55位及“广东省服务业民营企业50强”第18位;荣获由同花顺与财闻传联合主办的“2025财闻奖”颁发的“高质量上市公司奖”。","listedPrice":24.72},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大参林,603233,大参林股票,大参林股票老虎,大参林股票老虎国际,大参林行情,大参林股票行情,大参林股价,大参林股市,大参林股票价格,大参林股票交易,大参林股票购买,大参林股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}